Gilead Sciences, Inc., a prominent biopharmaceutical firm headquartered in Foster City, California, is at the forefront of discovering, developing, and marketing medical solutions across the United States, Europe, and other parts of the world. With a focus on medicines that fulfill unmet medical needs, Gilead Sciences has made significant strides in the field of HIV/AIDS treatment by supplying products like Biktarvy, Genvoya, and Truvada, among others. Furthering its commitment to tackling viral hepatitis, the company has also created life-changing drugs such as Harvoni, Vosevi, and Vemlidy. In the midst of the coronavirus pandemic, Gilead Sciences' Veklury, an intravenous injection, is gaining recognition for its efficacy in treating COVID-19. The company is also known for its products like Yescarta, Tecartus, Trodelvy, and Zydelig, which have made a significant impact in the field of oncology. Outside of this, the company is proactive in the development of treatments for pulmonary arterial hypertension and serious invasive fungal infections. Gilead Sciences has partnered with several firms including Merck & Co, Inc., Tango Therapeutics, Inc., and Galapagos NV, among others, to bring cutting-edge medical advancements to people across the globe.
Gilead Sciences's ticker is GILD
The company's shares trade on the LSE stock exchange
They are based in London, England
There are 11-50 employees working at Gilead Sciences
It is gilead.com
Gilead Sciences is in the Entertainment - Diversified industry
The following five companies are Gilead Sciences's industry peers: